Omics and Multi-Omics Analysis for the Early Identification and Improved Outcome of Patients with Psoriatic Arthritis

Abstract

The definitive diagnosis and early treatment of many immune-mediated inflammatory diseases (IMIDs) is hindered by variable and overlapping clinical manifestations. Psoriatic arthritis (PsA), which develops in ~30% of people with psoriasis, is a key example. This mixed-pattern IMID is apparent in entheseal and synovial musculoskeletal structures, but a definitive diagnosis often can only be made by clinical experts or when an extensive progressive disease state is apparent. As with other IMIDs, the detection of multimodal molecular biomarkers offers some hope for the early diagnosis of PsA and the initiation of effective management and treatment strategies. However, specific biomarkers are not yet available for PsA. The assessment of new markers by genomic and epigenomic profiling, or the analysis of blood and synovial fluid/tissue samples using proteomics, metabolomics and lipidomics, provides hope that complex molecular biomarker profiles could be developed to diagnose PsA. Importantly, the integration of these markers with high-throughput histology, imaging and standardized clinical assessment data provides an important opportunity to develop molecular profiles that could improve the diagnosis of PsA, predict its occurrence in cohorts of individuals with psoriasis, differentiate PsA from other IMIDs, and improve therapeutic responses. In this review, we consider the technologies that are currently deployed in the EU IMI2 project HIPPOCRATES to define biomarker profiles specific for PsA and discuss the advantages of combining multi-omics data to improve the outcome of PsA patients.

Biomarkers of heart failure: advances in omics studies

“…In previous studies, the following two strategies were often used to solve this problem: firstly, seeking markers, whose abundance rather than presence or absence correlates with a disease; secondly, profiles based on combinations of several markers that are more informative than single molecules. 139 This strategy was first applied to ovarian cancer. 140 In fact, this method has also made progress in HF.…”

Current State and Future Perspectives on Personalized Metabolomics

“…One of the most popular is the multi-omics approach, including the genomics, transcriptomics, proteomics, and metabolomics analysis at the single-subject (N-of-1) studies, where they are used to analyze the biomaterial of a single person. Several recent studies have illustrated the utility of the multi-omics longitudinal data to look for signs of reversible early disease or disease risk factors in single individuals [ 69 , 70 , 71 , 72 ].…”

The vitamin D receptor gene polymorphism rs1544410 T/T genotype as a predictor of factor vitamin D thresholds deficiency in patients with psoriasis vulgaris—A preliminary study

“…Although the precise cause and etio‐pathogenesis of psoriasis are unidentified, the innate and adaptive system, specifically T cells, is required for psoriasis pathogenesis 1,2 . Numerous epidemiologic researches revealed a relation of the low or deficit serum vitamin D levels (SDL) and psoriasis 3,4 …”

“…Although the precise cause and etio-pathogenesis of psoriasis are unidentified, the innate and adaptive system, specifically T cells, is required for psoriasis pathogenesis. 1,2 Numerous epidemiologic researches revealed a relation of the low or deficit serum vitamin D levels (SDL) and psoriasis. 3,4 The vitamin D receptor is a transcription factor that is activated by ligand variable that pertains to the superfamily of thyroid/retinoid/steroid hormone receptors.…”